Paper42985552PubMed
Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods.
Zhao J and 1 other. J Liq Biopsy, 2026.
Cite this record
ConductScience Library. Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods. Papers, record 42985552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42985552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Urine sediment (uSed) in molecular diagnosis of genitourinary cancer: From materials to methods.
- Journal
- J Liq Biopsy
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-11-06
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References121
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9176487 | Detection of bladder cancer recurrence by microsatellite analysis of urine. | Nat Med | 1997 | https://conductscience.org/library/papers/9176487 | PubMed |
| 2 | 29672570 | Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. | PLoS One | 2018 | https://conductscience.org/library/papers/29672570 | PubMed |
| 3 | 16328066 | Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder. | Oncol Rep | 2006 | https://conductscience.org/library/papers/16328066 | PubMed |
| 4 | 30654976 | Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer. | Urol Oncol | 2019 | https://conductscience.org/library/papers/30654976 | PubMed |
| 5 | 16697794 | Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma. | J Urol | 2006 | https://conductscience.org/library/papers/16697794 | PubMed |
| 6 | 39284767 | Effects of preanalytical sample collection and handling on comprehensive metabolite measurements in human urine biospecimens. | Am J Epidemiol | 2026 | https://conductscience.org/library/papers/39284767 | PubMed |
| 7 | 41449174 | Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO). | Sci Rep | 2025 | https://conductscience.org/library/papers/41449174 | PubMed |
| 8 | 42108902 | Surface-enhanced Raman spectroscopy for comprehensive urinalysis: advances, challenges, and clinical perspectives. | Analyst | 2026 | https://conductscience.org/library/papers/42108902 | PubMed |
| 9 | 41038864 | Robustness of urinary extracellular vesicle-derived MiRNA profiles over multiple days and the impact of urine concentration. | Sci Rep | 2025 | https://conductscience.org/library/papers/41038864 | PubMed |
| 10 | 37652824 | Preoperative urine sediment chromosomal instability level predicts urothelial cancer prognosis. | Urol Oncol | 2023 | https://conductscience.org/library/papers/37652824 | PubMed |
| 11 | 37055445 | Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy. | Sci Rep | 2023 | https://conductscience.org/library/papers/37055445 | PubMed |
| 12 | 35174071 | Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/35174071 | PubMed |
| 13 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 14 | 15669002 | Renal and urinary proteomics: current applications and challenges. | Proteomics | 2005 | https://conductscience.org/library/papers/15669002 | PubMed |
| 15 | 11751381 | Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. | Cancer Res | 2001 | https://conductscience.org/library/papers/11751381 | PubMed |
| 16 | 21144642 | A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity. | Eur Urol | 2011 | https://conductscience.org/library/papers/21144642 | PubMed |
| 17 | 22879988 | Detection of bladder cancer using proteomic profiling of urine sediments. | PLoS One | 2012 | https://conductscience.org/library/papers/22879988 | PubMed |
| 18 | 20875751 | Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments. | Urol Oncol | 2012 | https://conductscience.org/library/papers/20875751 | PubMed |
| 19 | 36855829 | Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario. | Technol Cancer Res Treat | 2023 | https://conductscience.org/library/papers/36855829 | PubMed |
| 20 | 37443032 | A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37443032 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42985552
GET https://conductscience.org/api/papers/v1/42985552/references?page=2